Exercising women of reproductive age are a major at-risk population for iron deficiency (ID) and anemia due to iron loss from both exercise related processes and menstrual bleeding.
A recent population-based screening study conducted in Australia examined the relationship between heavy menstrual bleeding (HMB), ID and anemia in recreationally active women aged 18 to 65.
Based on survey responses, the findings revealed that 10.6% of the participants were anemic and 30.9 % of the participants were defined to have HMB. Those presenting with HMB were younger, exercised fewer hours per week, and were more likely to have a history of ID or anemia.
Despite their healthy and physically active lifestyles, many of the women participating were unaware of the connection with HMB and low hemoglobin or iron levels—factors that can directly impact overall health, performance, and quality of life.
The study also pointed to a wider issue: while many participants were aware of iron-related fatigue and its effects, few were being routinely screened or treated. This highlights a clear gap in current diagnostic practices and the urgent need for accessible screening tools for testing females particularly in primary care and community health settings.
Importantly, the researchers emphasize the high prevalence of HMB and its strong association with self-reported ID and anemia—even among individuals taking iron supplements. This suggests that supplementation alone is not enough and that screening methods are crucial for identifying at-risk individuals and informing appropriate care pathways.
In this context, point-of-care testing offers an effective solution. By enabling fast, on-site hemoglobin assessment, HemoCue® Hb Systems support early detection and intervention—without the delays or barriers associated with traditional lab testing.
Key Takeaways:
This study underscores the importance of proactive screening for ID and anemia for patients with HMB —conditions that remain underdiagnosed despite their prevalence and health implications.
HemoCue’s hematology solutions offer immediate, lab-accurate results that support clinical decision-making at the point of care. These systems are uniquely positioned to help general practitioners, gynecologists, sports medicine professionals, and women’s health specialists identify iron deficiency and anemia early, improving care and outcomes for female patients.
Read the full publication here: The relationship between menorrhagia, iron deficiency, and anaemia in recreationally active females: An exploratory population based screening study.
J Sci Med Sport. 2024 Jul;27(7):437-450.
